Obesity


Healthcare Publication

Why Oncologists Are Prescribing GLP-1s

When cancer specialists embrace – and when they avoid – this revolutionary drug class.
Healthcare Publication

From Weight Lost to Life Gained

What Patients Need Next and Who Will Deliver It
Obesity News

Global consumer perceptions on obesity: Ipsos reveals findings for World Obesity Day

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.
Obesity Survey

Obesity’s hidden toll: seven in ten people living with obesity report life-wide impact – and most still blame themselves

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.
Healthcare Survey

Low awareness of GLP-1s globally, but high in the most advanced economies

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
Healthcare Publication

Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market

Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
Healthcare Publication

Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?

Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
Ipsos Update Publication

Ipsos Update – December 2024

Security, Inflation, Perils of Perception … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.